Validation in Spanish of a screening questionnaire for the detection of psoriatic arthritis in patients with psoriasis

Rheumatology (United Kingdom)

Volumn 52, Issue 3, 2013, Pages 510-514

  Garrott, Leandro G Ferreyra ^a   Soriano, Enrique R ^a   Rosa, Javier E ^a   Navarta, David A ^a   Saucedo, Carla ^a   Scolnik, Marina ^a   Bedran, Zaida ^a   Sabelli, Mirtha ^a   García, Maria V ^a   Anselmi, Carolina ^a   Galimberti, Ricardo ^a   Catoggio, Luis J ^a   Husni, M Elaine ^b   Qureshi, Abrar A ^c  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

PASE; Psoriasis; Psoriatic arthritis; Screening questionnaire

Indexed keywords

ADULT; ARTICLE; DERMATOLOGIST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS SCREENING AND EVALUATION QUESTIONNAIRE; QUESTIONNAIRE; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; LANGUAGE; MASS SCREENING; MIDDLE AGED; OSTEOARTHRITIS; PSORIASIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSLATING;

EID: 84874098590     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes306     Document Type: Article

References (23)

1. Alamanos Y, Papadopoulos NG, Voulgari PV et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J Rheumatol 2003;30:2641-4.
2. Gabriel SE. The epidemiology of psoriatic arthritis. J Rheumatol 2001;28:678.
3. Gelfand JM, Gladman DD, Mease PJ et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573.
4. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009;160:1040-7.
5. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50.
6. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
7. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl. 2):ii14-17.
8. Lawrence RC, Hochberg MC, Kelsey JL et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16: 427-41.
9. Soriano ER, Rosa J, Velozo E et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology 2011;50:729-34.
10. Alenius GM, Stenberg B, Stenlund H, Lundblad M, Dahlqvist SR. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002;29: 2577-82.
11. Dominguez P, Gladman DD, Helliwell P et al. Development of screening tools to identify psoriatic arthritis. Curr Rheumatol Rep 2010;12:295-9.
12. Dominguez P, Husni ME, Garg A, Qureshi AA. Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire and the role of dermatologists: a report from the GRAPPA 2009 annual meeting. J Rheumatol 2011;38:548-50.
13. Dominguez PL, Husni ME, Holt EW, Tyler S, Qureshi AA. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009;301:573-9.
14. Gladman DD, Schentag CT, Tom BD et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009;68:497-501.
15. Husni ME, Meyer KH, Cohen DS, Mody E, Qureshi AA. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007; 57:581-7.
16. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54: 2665-73.
17. Gladman DD, Mease PJ, Strand V et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70.
18. Citera G, Arriola MS, Maldonado-Cocco JA et al. Validation and crosscultural adaptation of an Argentine Spanish version of the Health Assessment Questionnaire Disability Index. J Clin Rheumatol 2004;10:110-115.
19. Cardiel MH, Londono JD, Gutierrez E et al. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 2003;21:451-8.
20. Jones SD, Calin A, Steiner A. An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores. J Rheumatol 1996;23:407.
21. Taylor WJ, Harrison AA. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 2004;51:311-5.
22. Ihtatho D, Fadzil MH, Affandi AM, Hussein SH. Area assessment of psoriasis lesion for PASI scoring. Conf Proc IEEE Eng Med Biol Soc 2007;2007:3446-9.
23. Jemec GB, Wulf HC. The applicability of clinical scoring systems: SCORAD and PASI in psoriasis and atopic dermatitis. Acta Derm Venereol 1997;77:392-3.